It is a chemicals and materials private limited company based in Chhatral, Gujarat, India, established in 2008.
2008 | Chhatral, Gujarat, India | ActiveDi- Cal Pharma Private Limited, a active private limited company, was established on 06 November 2008 in Chhatral, Gujarat, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24110GJ2008PTC055370. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Its leadership includes Ashokbhai Vijaysinh Barot (Director), Sangeeta Mukur Barot (Director), Sharadbhai Prahaldbhai Patel (Director). Past directors included Dhananjay Ashokkumar Barot, Asmitaben Premalkumar Patel, Premal Babubhai Patel. It holds no open charges and ₹1.38 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Block No. 1139, Opp. G.E.B, Kadi Road Chhatral, Taluka - Kalol, Chhatral, Gujarat, 382729.
U24110GJ2008PTC055370
055370
06 November 2008
₹2.50 M
₹2.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Di- Cal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashokbhai Vijaysinh Barot | Director | 06 Nov 2008 | Current |
| Sangeeta Mukur Barot | Director | 06 Nov 2008 | Current |
| Sharadbhai Prahaldbhai Patel | Director | 06 Nov 2008 | Current |
| Asmitaben Premalkumar Patel | Director | 15 Feb 2020 | Current |
| Mukurdhvaj Yogeshkumar Barot | Director | 06 Nov 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Director | 13 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Di- Cal Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 97.23% decrease. The company also saw a substantial improvement in profitability, with a 72.8% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Di- Cal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹13,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2009 | Bank Of India | ₹1.38 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Di- Cal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Di- Cal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Di- Cal Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Di- Cal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Di- Cal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
A charge registered on 27 Jun 2009 via Charge ID 10167193 with Bank Of India was fully satisfied on 17 Jan 2023. was recorded as a recent event.
The activity Asmitaben Premalkumar Patel was appointed as a Director was appointed as a Director on 15 Feb 2020 & has been associated with this company since 5 years 9 months . was completed.
A charge with Bank Of India amounted to Rs. 13.80 M with Charge ID 10167193 was registered on 27 Jun 2009. was recorded as a recent event.
Ashokbhai Vijaysinh Barot was appointed as a Director was appointed as a Director on 06 Nov 2008 & has been associated with this company since 17 years 26 days . was recorded as a recent event.
The CIN of Di- Cal Pharma Private Limited is U24110GJ2008PTC055370.
Di- Cal Pharma Private Limited is headquartered at Block No. 1139, Opp. G.E.B, Kadi Road Chhatral, Taluka - Kalol, Chhatral, Gujarat, 382729.
Di- Cal Pharma Private Limited was incorporated on 06 November 2008.
The current directors of Di- Cal Pharma Private Limited are
The primary industry of Di- Cal Pharma Private Limited is Manufacturing.
Di- Cal Pharma Private Limited is unlisted.
The authorized capital of Di- Cal Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.
The compliance status of Di- Cal Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX